The Lancet publishes results of Phase Three trials of Sputnik V vaccine
MOSCOW, February 2. /TASS/.
The Lancet publishes results of Phase Three trials of Sputnik V vaccine
MOSCOW, February 2. /TASS/.
The Lancet publishes results of Phase Three trials of Sputnik V vaccine
MOSCOW, February 2. /TASS/.
The Lancet publishes results of Phase Three trials of Sputnik V vaccine
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
Duration of immunity of Sputnik V vaccine will be over 2 years, says Gamaleya center
MOSCOW, February 2. /TASS/.
